細胞分析の市場規模、シェア、動向分析レポート：製品・サービス別、手法別、プロセス別、最終用途別、地域別、セグメント別予測、2025年～2030年

細胞分析の市場規模と動向

世界の細胞分析市場規模は2024年に315億9,000万米ドルと推定され、2025～2030年にかけてCAGR 10.03％で成長すると予測されています。

この成長の背景には、慢性疾患の増加、細胞分析技術の進歩、創薬活動の増加があります。細胞分析は、慢性疾患の潜在的な治療法や治療法を特定するための重要なツールとして浮上しています。したがって、心血管疾患、がん、自己免疫疾患、神経疾患などの慢性疾患の有病率の増加は、細胞分析の需要を促進する可能性があります。米国がん協会によると、2024年には米国で新たに200万人以上のがん患者が診断されると予想されています。

細胞分析は、早期のがん診断からがんに関連する治療法やツールの開発まで、その応用が増加しており、腫瘍学セグメントでの人気がさらに高まっています。オンコロジーセグメントで事業を展開する企業は、先進的な治療法や治療を開発するため、細胞分析の進歩に向けた取り組みを強化しています。例えば、2024年3月、がん診断会社のSerum Detectは、早期がん発見のためのT細胞分析アプローチを米国がん研究協会（AACR）で発表する予定でした。このような医療企業による細胞分析の応用拡大への取り組みの増加は、予測期間中の市場成長を促進すると予想されます。

さらに、細胞分析の技術的進歩により、より高い精度と効率で結果を提供する自動細胞分析システムの開発が可能になりました。同様に、自動細胞イメージング、細胞計数、セルソーターなどの先端技術の開発により、研究者は細胞をより大規模に研究できるようになりました。例えば、2024年7月。NanoCellect Biomedicalは、画像誘導型細胞選別機VERLOの発売を発表しました。このセルソーターにより、研究者は相互作用する細胞を区別・選別することができ、細胞の相互作用を妨げることなく、細胞サブセットの正確な特性評価とその機能的表現型の検証が可能になります。このような細胞分析技術の進歩により、需要が増加し、予測期間中の市場成長が促進されると予想されます。

これに加えて、関連する複雑性を分析するために、創薬において細胞周期分析の採用が大幅に増加しています。同様に、細胞生物学、分子生物学、バイオインフォマティクス、プロテオミクス、ゲノミクスの進歩が進むにつれて、医薬品開発プロセスにおいて細胞ベースのアッセイを活用する意義が高まっています。細胞ベースのアッセイは、従来の毒性検査や医薬品安全性検査の手法に代わるアプローチを提供し、研究者は細胞毒性や細胞死を通じて、早期スクリーニングで検査化合物の問題点を特定することができます。このように、先進的治療に対するニーズの高まりに起因する創薬活動の増加は、細胞ベースアッセイの需要を増加させ、それによって市場の成長を促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞分析市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 細胞分析市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 細胞分析市場：製品・サービス別、推定・動向分析

• セグメントダッシュボード
• 世界の細胞分析市場の製品・サービス変動分析
• 世界の細胞分析材料市場規模と動向分析、製品・サービス別、2018～2030年
• 試薬・消耗品
• 機器
• アクセサリー
• ソフトウェア
• サービス

第5章 細胞分析市場： 手法別、推定・動向分析

• セグメントダッシュボード
• 世界の細胞分析市場の手法変動分析
• 世界の細胞分析市場規模と動向分析、手法別、2018～2030年
• フローサイトメトリー
• PCR
• 細胞マイクロアレイ
• 顕微鏡検査
• 分光光度計
• 先進的コンテンツスクリーニング
• その他

第6章 細胞分析材料市場：プロセス別、推定・動向分析

• セグメントダッシュボード
• 世界の細胞分析市場のプロセス変動分析
• 世界の細胞分析市場規模と動向分析、プロセス別、2018～2030年
• 細胞識別
• 細胞生存率
• 細胞シグナル伝達経路
• 細胞増殖
• 細胞カウント
• 細胞相互作用
• 細胞構造研究
• 単一細胞分析
• その他

第7章 細胞分析市場： 最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界の細胞分析市場の最終用途変動分析
• 世界の細胞分析市場の規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
• 病院と臨床検査ラボ
• 学術研究機関
• その他

第8章 細胞分析市場：地域別、推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • BD
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Miltenyl BIoTech
  • Revvity
  • New England Biolabs
  • Avantor, Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global cell analysis market, by region, 2018 - 2030 (USD Million)
• Table 3 Global cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 5 Global cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 6 Global cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 8 North America cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 9 North America cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 10 North America cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 11 North America cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 12 U.S. cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 13 U.S. cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 14 U.S. cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 15 U.S. cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 17 Canada cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 18 Canada cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 19 Canada cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Mexico cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 21 Mexico cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 22 Mexico cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 23 Mexico cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Europe cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 26 Europe cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 27 Europe cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 28 Europe cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Germany cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 30 Germany cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 31 Germany cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 32 Germany cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 33 UK cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 34 UK cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 35 UK cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 36 UK cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 37 France cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 38 France cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 39 France cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 40 France cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Italy cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 42 Italy cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 43 Italy cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 44 Italy cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Spain cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 46 Spain cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 47 Spain cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 48 Spain cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Denmark cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 50 Denmark cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 51 Denmark cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 52 Denmark cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Sweden cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 54 Sweden cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 55 Sweden cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 56 Sweden cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Norway cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 58 Norway cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 59 Norway cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 60 Norway cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 66 China cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 67 China cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 68 China cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 69 China cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 70 Japan cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 71 Japan cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 72 Japan cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 73 Japan cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 74 India cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 75 India cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 76 India cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 77 India cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 78 South Korea cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 79 South Korea cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 80 South Korea cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 81 South Korea cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Australia cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 83 Australia cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 84 Australia cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 85 Australia cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Thailand cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 87 Thailand cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 88 Thailand cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 89 Thailand cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Latin America cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 92 Latin America cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 93 Latin America cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 94 Latin America cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Brazil cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 96 Brazil cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 97 Brazil cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 98 Brazil cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 100 Argentina cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 101 Argentina cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 102 Argentina cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 103 MEA cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 105 MEA cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 106 MEA cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 107 MEA cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 108 South Africa cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 109 South Africa cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 110 South Africa cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 111 South Africa cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 117 UAE cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 118 UAE cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 119 UAE cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait cell analysis market, by product & service, 2018 - 2030 (USD Million)
• Table 121 Kuwait cell analysis market, by technique, 2018 - 2030 (USD Million)
• Table 122 Kuwait cell analysis market, by process, 2018 - 2030 (USD Million)
• Table 123 Kuwait cell analysis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Cell Analysis market: Market outlook
• Fig. 5 Cell Analysis market: Segment outlook
• Fig. 6 Cell Analysis market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Cell Analysis market driver impact
• Fig. 9 Cell Analysis market restraint impact
• Fig. 10 Cell Analysis market: Product & Service outlook and key takeaways
• Fig. 11 Cell Analysis market: Product & Service movement analysis
• Fig. 12 Reagents & consumables market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 13 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Software market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Service market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Cell Analysis market: Technique outlook and key takeaways
• Fig. 18 Cell Analysis market: Technique movement analysis
• Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Cell microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Microscopy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Spectrophotometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 High content-screening market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Other techniques market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Cell Analysis market: Process outlook and key takeaways
• Fig. 27 Cell Analysis market: Process movement analysis
• Fig. 28 Cell identification market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Cell viability market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Cell Signaling Pathwaysmarket estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Cell proliferation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Cell counting market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Cell interaction market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Cell structure study market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Cell Analysis market: End use outlook and key takeaways
• Fig. 38 Cell Analysis market: End use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Hospitals & clinical testing laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Other market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Global Cell Analysis market: Regional outlook and key takeaways
• Fig. 44 Global Cell Analysis market: Regional movement analysis
• Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Target Disease Prevalence
• Fig. 49 Key country dynamics
• Fig. 50 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Target Disease Prevalence
• Fig. 52 Key country dynamics
• Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Target Disease Prevalence
• Fig. 55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Target Disease Prevalence
• Fig. 59 Key country dynamics
• Fig. 60 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Target Disease Prevalence
• Fig. 62 Key country dynamics
• Fig. 63 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Target Disease Prevalence
• Fig. 65 Key country dynamics
• Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Target Disease Prevalence
• Fig. 68 Key country dynamics
• Fig. 69 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Target Disease Prevalence
• Fig. 71 Key country dynamics
• Fig. 72 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Target Disease Prevalence
• Fig. 74 Key country dynamics
• Fig. 75 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Target Disease Prevalence
• Fig. 77 Key country dynamics
• Fig. 78 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Target Disease Prevalence
• Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Target Disease Prevalence
• Fig. 84 Key country dynamics
• Fig. 85 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Target Disease Prevalence
• Fig. 87 Key country dynamics
• Fig. 88 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Target Disease Prevalence
• Fig. 90 Key country dynamics
• Fig. 91 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Target Disease Prevalence
• Fig. 93 Key country dynamics
• Fig. 94 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Target Disease Prevalence
• Fig. 96 Key country dynamics
• Fig. 97 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Target Disease Prevalence
• Fig. 99 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Key country dynamics
• Fig. 101 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Target Disease Prevalence
• Fig. 103 Key country dynamics
• Fig. 104 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 105 Target Disease Prevalence
• Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 107 Key country dynamics
• Fig. 108 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 109 Target Disease Prevalence
• Fig. 110 Key country dynamics
• Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 112 Target Disease Prevalence
• Fig. 113 Key country dynamics
• Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 115 Target Disease Prevalence
• Fig. 116 Key country dynamics
• Fig. 117 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 118 Target Disease Prevalence

Cell Analysis Market Size & Trends:

The global cell analysis market size was estimated at USD 31.59 billion in 2024 and is projected to grow at a CAGR of 10.03% from 2025 to 2030. This growth can be attributed to the increasing prevalence of chronic diseases, advancements in cell analysis technologies, and the growing number of drug discovery activities. Cell analysis has emerged as an important tool for the identification of potential therapies and treatments for chronic diseases. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, autoimmune diseases, neurological disorders, and others can drive the demand for cell analysis. According to the American Cancer Society, over 2 million new cancer cases are expected to be diagnosed in the U.S. in 2024.

Cell analysis has witnessed an increase in its application, from early-stage cancer diagnostics to the development of cancer-associated therapies and tools, which has further increased its popularity in the oncology sector. The players operating in the oncology sector are increasing their efforts for advancements in cell analysis to develop advanced therapies and treatments. For instance, in March 2024, a cancer diagnostics company, Serum Detect, was set to launch the T-cell analysis approach for early cancer detection at the American Association for Cancer Research (AACR). Such increasing efforts by healthcare companies to increase the application of cell analysis are anticipated to drive market growth over the forecast period.

Moreover, technological advancements in cell analysis have enabled the development of automated cell analysis systems that offer results with better accuracy and efficiency. Similarly, the development of advanced technologies such as automated cell imaging, cell counting, and cell sorters allows researchers to study cells on a much larger scale. For instance, in July 2024. NanoCellect Biomedical announced the launch of VERLO, an image-guided cell sorter. This cell-sorter allows the researchers to distinguish & sort interacting cells, enabling precise characterization of cell subsets & validation of their functional phenotypes without disturbing the cell interactions. Such advancements in cell analysis technologies are anticipated to increase demand and drive market growth over the forecast period.

In addition to this, the adoption of cell cycle analysis has significantly increased in drug discovery to analyze the associated complexities. Similarly, the increasing advancements in cell biology, molecular biology, bioinformatics, proteomics, and genomics have increased the significance of utilizing cell-based assays in the drug development process. Cell-based assays offer an alternative approach to the conventional methods of toxicity and drug safety testing and allow researchers to identify problems with tested compounds in early screening through cytotoxicity and cell deaths. Thus, the increasing drug discovery activities owing to the rising need for advanced treatments are anticipated to increase the demand for cell-based assays, thereby driving the market growth.

Global Cell Analysis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cell analysis market report based on product & service, technique, process, end-use, and region.

• Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
• Reagents & Consumables
• Instruments
• Accessories
• Software
• Service
• Technique Outlook (Revenue, USD Million, 2018 - 2030)
• Flow Cytometry
• PCR
• Cell Microarrays
• Microscopy
• Spectrophotometry
• High Content-Screening
• Other Techniques
• Process Outlook (Revenue, USD Million, 2018 - 2030)
• Cell Identification
• Cell Viability
• Cell Signaling Pathways
• Cell Proliferation
• Cell Counting
• Cell Interaction
• Cell Structure Study
• Single-cell Analysis
• Others
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Testing Laboratories
• Academic & Research Institutes
• Other
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Technique Segment
  • 1.2.3. Process Segment
  • 1.2.4. End use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Analysis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Advancements in cell analysis technologies
    • 3.2.1.3. Growing number of drug discovery activities
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Complexity of cell analysis techniques
• 3.3. Cell Analysis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Analysis Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cell Analysis Market Product & Service Movement Analysis
• 4.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Reagents & Consumables
  • 4.4.1. Reagents & Consumables market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Accessories
  • 4.6.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Software
  • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Service
  • 4.8.1. Service market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cell Analysis Market: Technique Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cell Analysis Market Technique Movement Analysis
• 5.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
• 5.4. Flow Cytomtery
  • 5.4.1. Flow Cytomtery market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. PCR
  • 5.5.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Cell Microarrays
  • 5.6.1. Cell Microarrays market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Microscopy
  • 5.7.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Spectrophotometry
  • 5.8.1. Spectrophotometry market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. High Content-Screening
  • 5.9.1. High Content-Screening market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Other Techniques
  • 5.10.1. Other Techniques market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cell Analysis Materials Market: Process Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Cellular Starting Materials Market Process Movement Analysis
• 6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
• 6.4. Cell Identification
  • 6.4.1. Cell Identification market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Cell Viability
  • 6.5.1. Cell Viability market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Cell Signaling Pathways
  • 6.6.1. Cell Signaling Pathwaysmarket estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Cell Proliferation
  • 6.7.1. Cell Proliferation market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Cell Counting
  • 6.8.1. Cell Counting market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Cell Interaction
  • 6.9.1. Cell Interaction market estimates and forecasts 2018 to 2030 (USD Million)
• 6.10. Cell Structure Study
  • 6.10.1. Cell Structure Study market estimates and forecasts 2018 to 2030 (USD Million)
• 6.11. Single-cell Analysis
  • 6.11.1. Single-cell Analysis market estimates and forecasts 2018 to 2030 (USD Million)
• 6.12. Others
  • 6.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cellular Starting Materials Market: End use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Cellular Starting Materials Market End use Movement Analysis
• 7.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Hospitals & Clinical Testing Laboratories
  • 7.5.1. Hospitals & Clinical Testing Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Other
  • 7.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cell Analysis Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Target disease prevalence
    • 8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Target disease prevalence
    • 8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Target disease prevalence
    • 8.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Target disease prevalence
    • 8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Target disease prevalence
    • 8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Target disease prevalence
    • 8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Target disease prevalence
    • 8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Target disease prevalence
    • 8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Target disease prevalence
    • 8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Target disease prevalence
    • 8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Target disease prevalence
    • 8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Target disease prevalence
    • 8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Target disease prevalence
    • 8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Target disease prevalence
    • 8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Target disease prevalence
    • 8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Target disease prevalence
    • 8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Target disease prevalence
    • 8.6.7.4. Regulatory framework
    • 8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Target disease prevalence
    • 8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Target disease prevalence
    • 8.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Target disease prevalence
    • 8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Target disease prevalence
    • 8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. Target disease prevalence
    • 8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Target disease prevalence
    • 8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Danaher
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. BD
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Merck KGaA
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Agilent Technologies, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Bio-Rad Laboratories, Inc.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Miltenyl Biotech
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Revvity
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. New England Biolabs
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Avantor, Inc.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives